ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Mark Israel To Direct Norris Cotton Center

October 19, 2001

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006